Close Menu

The New York Times reports that some academic scientists and physicians are tired of the notation next to their names that indicates that they have accepted money from a drug, food, or medical device company. They now reject honoraria in hopes of restoring their good names. "It is not worth it to be under suspicion," says Brigham and Women's Peter Libby.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.